The Academic Respiratory Initiative for Pulmonary Health (TARIPH) National Medical Research Council Open Fund-Large Collaborative Grant (NMRC OF-LCG)
Pioneering Asian-Centric Respiratory Health Research
The Academic Respiratory Initiative for Pulmonary Health (TARIPH), a national research platform led by Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), is leading a multi-institutional research programme after being awarded Singapore’s first national research grant for respiratory health in 2024.
Under the $10 million Open Fund-Large Collaborative Grant (OF-LCG) supported by the National Research Foundation, Singapore (NRF) and administered by the Singapore Ministry of Health (MOH)’s National Medical Research Council, TARIPH brings together researchers from nine organisations. This includes research institution, public healthcare institutions across all three public healthcare clusters, and public agencies, tapping into the full spectrum of research capabilities in Singapore to conduct Asian-centric lung health research across five different and integrated themes.
In addition, this five-year programme is the first OF-LCG to embed patients and caregivers as key partners to drive patient-centric translational research on respiratory health, co-creating solutions that bridge the gap between scientific discovery and real-world patient needs.
Breathing Life into Asian Respiratory Research
Learn how TARIPH brings together clinicians, scientists, and patient partners to address critical knowledge gaps in Asian lung health. Through collaborative, Asian-centric research, we are advancing innovations ranging from “lungs-in-a-dish” bioresources and climate-based health forecasting to strategies for earlier diagnosis and more targeted treatments that improve respiratory outcomes across Singapore and Asia.
Advancing Asian Lung Health Through Five Integrated Research Themes
Awarded in 2024, the five-year TARIPH programme focuses on factors unique to Asia. By providing a clearer understanding of the health, environmental, social, and cultural needs of patients with lung diseases, we aim to develop personalised and precision-tailored treatments for Asian populations.

1. Multi-ethnic Endo-Phenotyping of Asthma and COPD (MEPAC)
Aims to increase awareness of chronic lung diseases with early detection, and strengthen diagnostic and management tools for asthma in primary care. This theme examines how diseases like COPD develop differently across Asian ethnic groups and addresses complex issues like the side effects of long-term steroid use.
2. Burden & biology of Post-Intensive Care Syndrome (2B-PICS)
Examines the long-term impact of an Intensive Care Unit (ICU) stay on patients with respiratory diseases. The focus is on post-intensive care syndrome (PICS) to identify and predict its development, allowing healthcare providers to better manage patient care and recovery after discharge.
3. CEllular Models of respiratory disease for Asian Phenotyping (CEMAP)
Develops a national repository of "lungs-in-a-dish" cellular models. This readily accessible Asian-centric bioresource will be used for lung disease research, drug screening, and rapid deployment against potential future pandemic threats ("Disease X").
4. FOrecasting COPD and Asthma attendances using Large-scale time Series for patient and policy support (FOCALS)
Develops, models, and tests the implementation of a nation-wide forecasting tool for asthma and COPD. Based on weather changes (like haze or extreme rain), patients receive SMS alerts allowing them to make informed decisions to manage health risks, while helping hospitals project surges in emergency demand.
5. Climate change, Allergy, Pollution, and the Environment (CAPE)
Examines the role of environmental and climate change on respiratory diseases. By tapping into three established local cohort studies, researchers investigate how early-life environmental exposures, genetics, Asian diets, and lifestyle habits influence the development of respiratory allergies and diseases.
Patient-Centric Research
The TARIPH programme takes a novel approach by embedding patients as key partners, not just participants. Through the TARIPH Lung Patient Network, patient views and voices are actively sought out in the design, execution, and reporting of research, ensuring the work addresses the real-world needs of Singaporeans living with chronic lung conditions.

Asthma patient partners contributing inputs to improve study design (Theme 1)

ICU patient partners providing inputs to reduce questionnaire burden on post-ICU patients (Theme 2)

Asthma patient partners providing inputs to refine interview guide and health message templates (Theme 4)

Patient partners with respiratory diseases sharing their lived experiences during a Breath Workshop
News & Media Coverage
Press Releases
Asian-specific multimorbidity significantly amplifies Asthma and COPD costs in Singapore, with healthcare burden projected in the billions over the next two decades
(Joint Press Release — NUS SSHSPH & NTU LKCMedicine | 17 June 2026)
NTU Singapore’s TARIPH Centre leads multi-institution research programme with first national research grant for lung health
(Joint Press Release — NTU, NUS, NUHS, SGH, TTSH | 23 January 2025)
Media Coverage
2026
本地研究:哮喘与慢阻肺住院需求料大增 未来20年医疗负担逾百亿元
(Lianhe Zaobao | 17 June 2026)
Asthma, COPD could cost S’pore over S$10B by 2043 as patients face multiple chronic illnesses: NUS study
(MS News | 17 June 2026)
本地研究:哮喘与慢阻肺住院需求料大增未来20年医疗负担逾百亿元
(YiOu News | 17 June 2026)
Lung cell bank aims to help Singapore breathe easy in case of outbreak
(The Straits Times | 20 April 2026)
2025
南大获1000万元资助 与多机构研究肺部健康
(Lianhe Zaobao | 24 January 2025)
南大获1000万元资助研究改善亚洲人肺部健康
(Lianhe Zaobao | 24 January 2025)
New research programme draws scientists from 9 organisations to better understand lung health
(The Straits Times | 23 January 2025)
住持严重哮喘 肺功能剩30% 参与医学研究 盼肺病患者受惠
(Shin Min Daily News | 23 January 2025)
Singapore’s respiratory health gets a boost with $10 million research grant
(Medical News | 23 January 2025)
Global healthcare features on Singapore's milestone $10M respiratory research grant
(Mirage News | 23 January 2025)
Publications & Research Outputs
Our research outputs reflect a commitment to our mission of 'bringing research to patients through partnerships'. We strive for scientific excellence which advances respiratory and critical care medicine for Singaporeans.
For a full list of journal articles and publications arising from the TARIPH LCG programme, click here.
Contact Us
To learn more about the TARIPH programme, explore research collaboration opportunities, or get involved in our research through Patient & Public Involvement (PPI) activities, please reach out to us at TARIPH@ntu.edu.sg.